These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Effectiveness and tolerance of genetically engineered vaccines for hepatitis B--a comparative study].
    Author: Schmid K, Strebl H, Heck KJ, Weltle D, Raithel HJ.
    Journal: Gesundheitswesen; 1992 May; 54(5):219-22. PubMed ID: 1535816.
    Abstract:
    The two hepatitis B vaccines produced by gene technology that are presently available in Germany, were compared in respect of efficacy and tolerance in 80 nurses (female and male) who were under training. Both vaccines proved to be highly effective and well tolerated. In respect of the achieved anti-HBs titer, however, the two vaccines differed significantly from each other. Using the 20 micrograms HBs antigen, the antibody titers obtained were higher by a factor of 1.8. The article gives update recommendations in respect of hepatitis B vaccination as a preventive measure in risk groups.
    [Abstract] [Full Text] [Related] [New Search]